The Borrelia burgdorferi surface lipoprotein OspC is a critical virulence factor, but its precise role in the establishment of B. burgdorferi infection remains unclear. To determine whether OspC affects the host response at the site of inoculation of the bacterium, the recruitment of macrophages and neutrophils, and the production of cytokines, were examined at the site of infection by wild-type, ospC mutant, and complemented mutant B. burgdorferi. Of the 21 cytokines tested, MCP-1, KC, and VEGF were found at increased levels at the site of inoculation of B. burgdorferi, and the levels varied with production of OspC at one or more time points over the one-week course of infection. The kinetics of expression and the dependence on OspC production by B. burgdorferi varied among the cytokines. The production of KC and MCP-1, and the appearance of monocytic infiltrates, correlated with the presence of the bacteria, rather than with OspC, specifically. In contrast, VEGF production was not correlated simply to the presence of the bacteria, and is influenced by the presence of OspC. In in vitro assays, OspC and B. burgdorferi expressing OspC stimulated growth of endothelial cells more than did the controls. These data suggest the possibility of a novel role for OspC in the life of B.
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10:1 or 100:1 in 1 ml of BMMφ medium without antibiotics. Control wells were incubated with medium alone. The plates were centrifuged at 200 x g for 15 minutes at room temperature to synchronize infection and maximize bacteria-macrophage contact. The plates were incubated at 37°C in an atmosphere of 5% CO 2 for 3h. After infection the supernatants from each well were collected, filtered through a 0.22µm filter and stored at -80 o C for subsequent analysis of cytokine secretion. The cells were harvested for analysis of mRNA.
In vitro infection of endothelial cells with B. burgdorferi
The Ea.hy926 endothelial cell line (18, 19) was plated on Matrigel (BD Biosciences, San Jose, CA), or on conventional tissue culture treated plastic, in standard growth medium (Dulbecco's modified Eagle medium with high glucose, 10% heat-inactivated fetal bovine serum (Gibco, Grand Island, NY) and HAT Media Supplement (Sigma-Aldrich, St. Louis, MO), and 2 mM L-glutamine). Two days after plating, the cells were treated with purified VEGF (obtained from the NCI repository), or infected with B. burgdorferi at an MOI of 10:1. Growth of the endothelial cells was monitored and structure formation quantified visually for 7-10 days, depending on the lot of Matrigel. Data were analyzed for statistical significance using one-way repeated measures ANOVA and Dunnett's post-test. Supernatants from B. burgdorferi-infected wells were taken for analysis of VEGF levels by ELISA using the Quantikine Human VEGF Immunoassay (R&D Systems, Minneapolis, MN), following the manufacturer's protocol. In other experiments, the Ea.hy926 cells were plated in growth medium without antibiotics on 3 µm pore size transwell inserts and allowed to reach confluence over 2-3 days, then infected with B.
burgdorferi at an MOI of 20 and monitored over 72 hours. Bacteria that had crossed the membrane or remained in the inserts were enumerated, and data were analyzed using one-way repeated measures ANOVA followed by Bonferroni's multiple comparison test.
In similar experiments, purified recombinant proteins were also tested for effects on endothelial cell growth and structure formation. The purified MBP-βgal and MBP-OspC were on October 16, 2017 by guest http://iai.asm.org/ Downloaded from 7 described previously (2) . Purified proteins were tested at 1 and 10 µg/ml. The synthetic lipopeptide Pam3CSK4 (InvivoGen, San Diego, CA) was used at the same concentrations in some experiments.
Infections of C3H/HeN mice with B. burgdorferi
To infect mice, frozen aliquots of bacteria were thawed, washed, and cultured overnight at 32°C in BSK II. The bacteria were enumerated using a Petroff-Hausser counting chamber under dark field microscopy and were suspended in BSK II medium to 1.25 x 10 5 bacteria/ml.
C3H/HeN mice were inoculated intradermally in the dorsal thoracic area with 5x10 3 motile spirochetes in 40 µl of BSK II or were mock-infected with BSK II alone. To confirm the number of spirochetes injected into the mice, aliquots from each sample were plated on BSK II plates and the colonies enumerated. The injection sites were labeled with a marker immediately after inoculation to ensure that the samples would be collected from that site. The inoculation of cultured bacteria, as opposed to tick-mediated delivery, was used to ensure that equal numbers of bacterial cells were introduced into all animals. Mice were euthanized 6h, 1d, 2d and 7d later and skin samples were collected at the inoculation site, divided in 3 equal parts and snap-frozen in RNase-and DNase-free preweighed microfuge tubes.
Cytokine extraction from skin and analysis of cytokines by Luminex
Cytokines were extracted from skin samples using a slight modification of a protocol described previously (41) . Briefly, the samples were weighed and 1 ml of ice-cold cytokine extraction buffer was added. The buffer consisted of PBS, 0.1% Igepal CA-630, a nonionic detergent, and three protease inhibitors (0.01 TIU/ml aprotinin, 1 mM benzamidine, 1 µg/ml leupeptin 
RNA preparation and reverse transcription-PCR analysis
For the in vitro BMMφ infections total RNA was isolated using the RNeasy kit (Qiagen, Valencia, CA) as according to the manufacturer's instructions. The samples were then treated with the DNA-free kit from Ambion (Austin, TX) as described by the manufacturer. The DNA-free total RNA was reverse transcribed into cDNA in a final volume of 20 µl using 500 ng of RNA, 5 µM random hexamers, 10 mM dNTP mix, and SuperScript® III Reverse Transcriptase (Invitrogen, Carlsbad, CA). Quantitative PCR using SYBR green PCR master mix (Qiagen) was used to determine the expression of the cytokines in the samples. All reactions were performed for 40 cycles in a final volume of 25 µl in 96-well plates in a Stratagene (La Jolla, CA) MX3000p real-time thermocycler, and the data were analyzed using the accompanying software. For the quantification of the cytokines primers listed in Table 2 were used and the transcript levels are presented as a fold difference over WT infected samples after normalization to GAPDH values for the same samples.
For the mouse skin samples, the tissues were homogenized using an OMNI shredder (model TH-115) in buffer RLT provided by the RNeasy kit (Qiagen) and total RNA was isolated using the RNeasy kit according to the manufacturer's instructions (Qiagen). The samples were DNAse treated on column using the RNase-free DNase set from Qiagen as described by the manufacturer. DNA-free total RNA was then reverse transcribed, as described above. The 9 values are presented as copies of the cytokine normalized to mouse β-actin mRNA levels in the same samples. To allow quantification of the copy number in each sample a standard curve was created that consisted of known quantities of recombinant plasmid DNA specific for each gene tested.
DNA isolation and quantitative PCR
Skin samples were homogenized in 300 µl of buffer ATL provided by the DNeasy tissue kit (Qiagen) with an OMNI shredder (model TH-115) and the DNA was extracted from the tissues using the DNeasy tissue kit (Qiagen) according to the manufacturer's instructions. To obtain RNA-free DNA samples RNaseA (Roche, Basel, Switzerland) was added to the samples during the purification process prior to the passage of the homogenates through the Qiagen columns. To determine the spirochete load, real-time PCRs for B. burgdorferi flagellin (flaB) and for the mouse nidogen (nido) gene were performed using the primers described in Table 2 . The reactions were performed using SYBR green PCR master mix (Qiagen) for 40 cycles in a final volume of 25 µl in 96-well plates in a Stratagene MX3000p real-time thermocycler, and the data were analyzed using the accompanying software. Standards and samples were simultaneously amplified in the same plates. The flaB copy number standard contained purified B. burgdorferi DNA mixed with DNA isolated from uninfected mouse tissue. For the nido standard curve, purified mouse DNA was used.
Skin histopathology
Skin samples from the mouse infections described above were collected and fixed in 2 ml of formalin. The samples were embedded in paraffin and skin sections were stained with H&E by the Histology Core Facility at Tufts University. Dr. Lauren Richey, an independent pathologist who was blinded to the experimental design, scored the sections. 
Statistical analyses
Statistical analyses of all quantitative data were performed using GraphPad (GraphPad whether any observed differences in RNA transcript levels correspond to differences in cytokine production, the supernatants from each well were also analyzed for cytokine content.
The levels of cytokine mRNAs were normalized to that of the housekeeping gene 
Infection of C3H/HeN mice with B31 A3 WT, OspC mutant (∆C) and the complemented mutant (∆C/pOspC)
To determine the response of the innate immune system to B. burgdorferi that do or do not express OspC at the site of infection, C3H/HeN mice were inoculated intradermally in the dorsal thoracic area with 5x10 3 bacteria. Again, the strains tested were wild-type B31 A3 (WT), the OspC mutant (∆C), and the complemented mutant (∆C/pOspC). The dose used has been shown in previous work to ensure infection if OspC is present. As a control for the inoculation process mice were injected with the same volume of BSK II medium. At 6h, 1d, 2d and 7d after inoculation the mice were euthanized and skin samples were collected from the site of the injection. These time points were chosen because previous work showed that bacteria that do not express OspC are not recovered from the site of infection after 2d post infection (61) . The skin samples were homogenized and the cytokines were extracted from the tissues as described in Materials and Methods, based on a previously published protocol (41) . Subsequent in vivo experiments were performed as described above, except that the skin samples from the site of inoculation were split into 3 equal parts. One part was fixed and examined at the histologic level by a pathologist, and the other parts were used for cytokine extraction and nucleic acid extraction. The levels of MCP-1, KC and VEGF protein were quantified in parallel with the corresponding RNA levels, and all data were analyzed for statistical significance. 
Spirochete loads at various time points
The cytokines were detectable initially, declined, and then KC and MCP-1 rebounded.
To determine whether this pattern reflects bacterial numbers, the bacterial loads were determined by QPCR (Figure 3 ). There are bacteria detectable at 6h post infection but their 
Histopathologic analyses of skin from the site of B. burgdorferi infection in vivo
To determine how effector cells of the innate immune system respond to infection with the WT, the ∆C mutant and the ∆C/pOspC complemented mutant, the infiltration of immune cells was assessed at the site of the infection at 6h, 1d, 2d and 7d by histopathology. Skin sections were H&E stained and an independent pathologist who was blinded to the experimental design scored them for the presence of neutrophils, monocytes and the presence or formation of new capillaries or arterioles over time, which is the vascularization score. The results are presented in Table 3 . There was no statistically significant difference in the numbers of neutrophils or in vascularization at any time point under any infection condition.
In contrast, infiltration of monocytes in response to injection was seen by 1d, and the numbers of monocytes were statistically significantly higher in the mice infected with the WT 
Discussion
OspC is an outer surface protein that is abundantly expressed by Borrelia burgdorferi as the organism enters the mammalian host. OspC-deficient bacteria cannot establish infection even in the immunodeficient mouse strains that have been tested (25, 57) . It has also been shown that OspC expression is required only for a short time in order for the bacteria to The data presented here are consistent with previously published evidence (25, 54, 57) that the presence of OspC does not alter the host innate immune response to the bacteria. The data were normalized to the housekeeping gene GAPDH and expressed as fold difference compared to infection by the B31-A3 WT strain. The supernatants from the infections were collected and assayed using Luminex technology for the secretion of the same cytokines.
Shown are the means of all replicates from at least two independent determinations, + the standard errors; macrophages from C57BL/6 mice were similar, as were results from infections performed at MOI of 100. At the mRNA level, statistically significant differences were as follows:
for TNF-α and KC, p < 0.05 for WT-and ∆C-infected vs. uninfected, for MCP-1, p < 0.05 between WT-infected and uninfected macrophages, but there were no significant differences between infections by the different B. burgdorferi strains. At the protein level, there were no statistically significant differences between infections with any of the three B. burgdorferi strains for any cytokine, but for KC and TNF-α there were statistically significant differences (p < 0.05) between the infected and uninfected samples. Bacterial loads at the inoculation site were determined by QPCR using primers listed in Table 2 Ea.hy926 endothelial cells were plated on Matrigel, and after 2 days treated with VEGF at 10 ng/ml (~0.5 nM), Pam3CSK4 at 7 µM, or recombinant proteins at 1 µg/ml (~20 nM). Additional wells were infected with B. burgdorferi at an MOI of 10. Cellular growth and structure formation were quantified visually over seven to ten days, depending on the lot of Matrigel; three random on October 16, 2017 by guest http://iai.asm.org/ Downloaded from 
